A Study of a New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid Tumors
Clinical trial NCT03316638 · TERMINATED
Trial details
- NCT number
- NCT03316638
- Sponsor
- Pierre Fabre Medicament
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-24
- Primary completion
- 2021-10-30
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.